23-01-2019
104
Global Celiac Disease Drugs Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2023
Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers.

Scope of the Report:
This report studies the Celiac Disease Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Celiac Disease Drugs market by product type and applications/end industries.
The global Celiac Disease Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Celiac Disease Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis

Immunomedics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
First Line of Treatment
Second Line of Treatment

Market Segment by Applications, can be divided into
Hospital
Research

Table of Contents

Global Celiac Disease Drugs Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2023


Table of Contents

1 Celiac Disease Drugs Market Overview
1.1 Product Overview and Scope of Celiac Disease Drugs
1.2 Classification of Celiac Disease Drugs by Types
1.2.1 Global Celiac Disease Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Celiac Disease Drugs Revenue Market Share by Types in 2017
1.2.3 First Line of Treatment
1.2.4 Second Line of Treatment
1.3 Global Celiac Disease Drugs Market by Application
1.3.1 Global Celiac Disease Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Research
1.4 Global Celiac Disease Drugs Market by Regions
1.4.1 Global Celiac Disease Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Celiac Disease Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Celiac Disease Drugs (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Celiac Disease Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Celiac Disease Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Celiac Disease Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 BiolineRx
2.4.1 Business Overview
2.4.2 Celiac Disease Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BiolineRx Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Celiac Disease Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Innovate Biopharmaceuticals
2.6.1 Business Overview
2.6.2 Celiac Disease Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 ImmusanT
2.7.1 Business Overview
2.7.2 Celiac Disease Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ImmusanT Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Celiac Disease Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers Squibb Company
2.9.1 Business Overview
2.9.2 Celiac Disease Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Company Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Immunomedics
2.10.1 Business Overview
2.10.2 Celiac Disease Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Immunomedics Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Celiac Disease Drugs Market Competition, by Players
3.1 Global Celiac Disease Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Celiac Disease Drugs Players Market Share
3.2.2 Top 10 Celiac Disease Drugs Players Market Share
3.3 Market Competition Trend
4 Global Celiac Disease Drugs Market Size by Regions
4.1 Global Celiac Disease Drugs Revenue and Market Share by Regions
4.2 North America Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
5 North America Celiac Disease Drugs Revenue by Countries
5.1 North America Celiac Disease Drugs Revenue by Countries (2013-2018)
5.2 USA Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6 Europe Celiac Disease Drugs Revenue by Countries
6.1 Europe Celiac Disease Drugs Revenue by Countries (2013-2018)
6.2 Germany Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.4 France Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Celiac Disease Drugs Revenue by Countries
7.1 Asia-Pacific Celiac Disease Drugs Revenue by Countries (2013-2018)
7.2 China Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.5 India Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
8 South America Celiac Disease Drugs Revenue by Countries
8.1 South America Celiac Disease Drugs Revenue by Countries (2013-2018)
8.2 Brazil Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Celiac Disease Drugs by Countries
9.1 Middle East and Africa Celiac Disease Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
10 Global Celiac Disease Drugs Market Segment by Type
10.1 Global Celiac Disease Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Celiac Disease Drugs Market Forecast by Type (2018-2023)
10.3 First Line of Treatment Revenue Growth Rate (2013-2023)
10.4 Second Line of Treatment Revenue Growth Rate (2013-2023)
11 Global Celiac Disease Drugs Market Segment by Application
11.1 Global Celiac Disease Drugs Revenue Market Share by Application (2013-2018)
11.2 Celiac Disease Drugs Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Research Revenue Growth (2013-2018)
12 Global Celiac Disease Drugs Market Size Forecast (2018-2023)
12.1 Global Celiac Disease Drugs Market Size Forecast (2018-2023)
12.2 Global Celiac Disease Drugs Market Forecast by Regions (2018-2023)
12.3 North America Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.6 South America Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Celiac Disease Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Celiac Disease Drugs Picture
Table Product Specifications of Celiac Disease Drugs
Table Global Celiac Disease Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Celiac Disease Drugs Revenue Market Share by Types in 2017
Figure First Line of Treatment Picture
Figure Second Line of Treatment Picture
Table Global Celiac Disease Drugs Revenue (Million USD) by Application (2013-2023)
Figure Celiac Disease Drugs Revenue Market Share by Applications in 2017
Figure Hospital Picture
Figure Research Picture
Table Global Market Celiac Disease Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Celiac Disease Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Celiac Disease Drugs Type and Applications
Table Roche Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Celiac Disease Drugs Type and Applications
Table Merck Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Celiac Disease Drugs Type and Applications
Table Johnson & Johnson Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table BiolineRx Basic Information, Manufacturing Base and Competitors
Table BiolineRx Celiac Disease Drugs Type and Applications
Table BiolineRx Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Celiac Disease Drugs Type and Applications
Table Pfizer Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Innovate Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Innovate Biopharmaceuticals Celiac Disease Drugs Type and Applications
Table Innovate Biopharmaceuticals Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table ImmusanT Basic Information, Manufacturing Base and Competitors
Table ImmusanT Celiac Disease Drugs Type and Applications
Table ImmusanT Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Celiac Disease Drugs Type and Applications
Table Novartis Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Celiac Disease Drugs Type and Applications
Table Bristol-Myers Squibb Company Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Immunomedics Basic Information, Manufacturing Base and Competitors
Table Immunomedics Celiac Disease Drugs Type and Applications
Table Immunomedics Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Celiac Disease Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Celiac Disease Drugs Revenue Share by Players (2013-2018)
Figure Global Celiac Disease Drugs Revenue Share by Players in 2016
Figure Global Celiac Disease Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Celiac Disease Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Celiac Disease Drugs Revenue Market Share in 2017
Figure Global Celiac Disease Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Celiac Disease Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Celiac Disease Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Celiac Disease Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Celiac Disease Drugs Revenue Market Share by Regions in 2017
Figure North America Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure South America Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Table North America Celiac Disease Drugs Revenue by Countries (2013-2018)
Table North America Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Celiac Disease Drugs Revenue Market Share by Countries in 2017
Figure USA Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Table Europe Celiac Disease Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Celiac Disease Drugs Revenue Market Share by Countries in 2017
Figure Germany Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure UK Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure France Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Celiac Disease Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Celiac Disease Drugs Revenue Market Share by Countries in 2017
Figure China Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure India Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Table South America Celiac Disease Drugs Revenue by Countries (2013-2018)
Table South America Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Celiac Disease Drugs Revenue Market Share by Countries in 2017
Figure Brazil Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Celiac Disease Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Celiac Disease Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Celiac Disease Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
Table Global Celiac Disease Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Celiac Disease Drugs Revenue Share by Type (2013-2018)
Figure Global Celiac Disease Drugs Revenue Share by Type (2013-2018)
Figure Global Celiac Disease Drugs Revenue Share by Type in 2017
Table Global Celiac Disease Drugs Revenue Forecast by Type (2018-2023)
Figure Global Celiac Disease Drugs Market Share Forecast by Type (2018-2023)
Figure Global First Line of Treatment Revenue Growth Rate (2013-2018)
Figure Global Second Line of Treatment Revenue Growth Rate (2013-2018)
Table Global Celiac Disease Drugs Revenue by Application (2013-2018)
Table Global Celiac Disease Drugs Revenue Share by Application (2013-2018)
Figure Global Celiac Disease Drugs Revenue Share by Application (2013-2018)
Figure Global Celiac Disease Drugs Revenue Share by Application in 2017
Table Global Celiac Disease Drugs Revenue Forecast by Application (2018-2023)
Figure Global Celiac Disease Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospital Revenue Growth Rate (2013-2018)
Figure Global Research Revenue Growth Rate (2013-2018)
Figure Global Celiac Disease Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Celiac Disease Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Celiac Disease Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Celiac Disease Drugs Revenue Market Forecast (2018-2023)
Figure Europe Celiac Disease Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Celiac Disease Drugs Revenue Market Forecast (2018-2023)
Figure South America Celiac Disease Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Celiac Disease Drugs Revenue Market Forecast (2018-2023)

Enquiry Before Buying

*

*
*
*
*
*

Request Sample


*

*
*
*
*
*